1,650 Shares in Xylem Inc. $XYL Purchased by Spinnaker Trust

Spinnaker Trust bought a new stake in shares of Xylem Inc. (NYSE:XYL) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,650 shares of the industrial products company’s stock, valued at approximately $213,000.

Several other large investors have also modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of Xylem by 1.3% during the first quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock valued at $3,465,122,000 after buying an additional 362,127 shares during the period. Swedbank AB boosted its position in shares of Xylem by 13.9% during the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock valued at $564,906,000 after buying an additional 531,890 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Xylem by 7.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock valued at $480,767,000 after buying an additional 274,123 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Xylem by 689.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock valued at $443,074,000 after buying an additional 3,239,203 shares during the period. Finally, Northern Trust Corp increased its stake in Xylem by 2.9% in the 1st quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock worth $401,743,000 after buying an additional 94,560 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

NYSE:XYL opened at $151.52 on Friday. Xylem Inc. has a one year low of $100.47 and a one year high of $154.27. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.96. The firm has a market cap of $36.89 billion, a price-to-earnings ratio of 38.95, a PEG ratio of 2.50 and a beta of 1.13. The firm’s fifty day moving average is $144.59 and its two-hundred day moving average is $133.92.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The business had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same period in the prior year, the company posted $1.11 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Research analysts expect that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem’s dividend payout ratio is presently 41.13%.

Insider Activity

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at $413,861.72. This represents a 25.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Robert W. Baird set a $178.00 price target on shares of Xylem in a research note on Wednesday. Royal Bank Of Canada boosted their price target on Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a report on Wednesday. Argus set a $170.00 price target on Xylem in a report on Wednesday. Mizuho set a $160.00 price target on Xylem in a report on Wednesday. Finally, UBS Group boosted their price objective on shares of Xylem from $164.00 to $168.00 and gave the stock a “buy” rating in a research note on Tuesday, August 5th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $166.20.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.